Following the announcement from the World Health Organization that declared Covid-19 as a pandemic, the Indonesian government continues making adjustment and taking steps to deal with the outbreak. As of 23 March 2020, there were 579 confirmed COVID-19 cases, with 49 deaths and 30 recovery. Globally, the pneumonia-like illness has infected more than 330,000 people and taken at least 14,000 lives.
Amidst this outbreak, the Indonesian Central Statistics Agency (“BPS“) noted an increase in the export of protective masks from Indonesia to trading partner countries by an average of 3,000% during February 2020. BPS recorded that the value of the export of masks increased from USD 2,1 million in January 2020, to USD 74,7 million in February 2020.
Ironically, the increase in the export of masks occurs when Indonesia is suffering from a shortage of protective masks due to panic buying and an increase of price. In a bid to safeguard domestic supply and to protect the public health of the Indonesian public, the government issued the Minister of Trade Regulation No. 23 of 2020 on the Temporary Ban of Export of Antiseptics, Raw Materials for Masks, Personal Protective Equipment and Masks on 17 March 2020 (“Regulation“).
Based on the Regulation, exporters are prohibited from exporting antiseptics, raw materials for masks, personal protective equipment and masks that fall under the following Tariff Post/Harmonized System (“HS“):
The export of the above items is prohibited from 18 March 2020 until 30 June 2020. Exporters who violate the Regulation may be subject to sanctions in accordance with the provisions of the prevailing laws and regulations.
Our Commentary
Indonesia’s move follows the move of other countries, including EU members and some ASEAN countries, to ensure that sufficient supplies of these items remain within the country. The next natural progression is for the government to cooperate with the medical industry to boost production and set a ceiling price for these items, and we will keep our clients updated of any development in this area.
***
AHP Client Alert is a publication of Assegaf Hamzah & Partners. It brings an overview of selected Indonesian laws and regulations to the attention of clients but is not intended to be viewed or relied upon as legal advice. Clients should seek advice of qualified Indonesian legal practitioners with respect to the precise effect of the laws and regulations referred to in AHP Client Alert. Whilst care has been taken in the preparation of AHP Client Alert, no warranty is given as to the accuracy of the information it contains and no liability is accepted for any statement, opinion, error or omission.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.